India to Mexico: Moxifloxacin Export Trade Route
India has recorded 10 verified shipments of Moxifloxacin exported to Mexico, representing a combined trade value of $515.9K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $51.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 54% of total export value with 3 shipments worth $279.7K USD. On the buying side, GRADINTER S C is the largest importer in Mexico with $167.1K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, HETERO LABS LIMITED, MICRO LABS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mexico Moxifloxacin corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $515.9K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's moxifloxacin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $51.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.6%, placing it at rank #5 among India's top moxifloxacin export destinations globally.
On the import side, key buyers of Indian moxifloxacin in Mexico include GRADINTER S C, XXAROXXPHAXXA SXX DXXC VX, COIMPORTEX SERVICIOS ADUANALES S.C. and 2 others. GRADINTER S C is the single largest importer with 1 shipments valued at $167.1K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portBANGALORE AIR
Market Position
- Global rank#5
- Annual growth+19.6%
- Demand growth+18.6%
- Regulatory ease70/100
Top 10 Indian Moxifloxacin Exporters to Mexico
Showing top 10 of 3 Indian suppliers exporting Moxifloxacin to Mexico, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $93.2K per shipment | 3 | $279.7K | 54.2% |
| 2 | HETERO LABS LIMITED Avg $52.0K per shipment | 3 | $155.9K | 30.2% |
| 3 | MICRO LABS LIMITED Avg $20.1K per shipment | 4 | $80.2K | 15.5% |
This table shows the top 10 of 3 Indian companies exporting moxifloxacin to Mexico, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, HETERO LABS LIMITED, MICRO LABS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 3 shipments worth $279.7K USD, giving it a 54% market share.
Top 10 Moxifloxacin Importers in Mexico
Showing top 10 of 5 known buyers in Mexico receiving Moxifloxacin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian moxifloxacin in Mexico include GRADINTER S C, XXAROXXPHAXXA SXX DXXC VX, COIMPORTEX SERVICIOS ADUANALES S.C., M S, GRADINTER S.C. The largest importer is GRADINTER S C, accounting for $167.1K USD across 1 shipments — representing 32% of all moxifloxacin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GRADINTER S C | 1 | $167.1K | 32.4% |
| 2 | XXAROXXPHAXXA SXX DXXC VX | 3 | $155.9K | 30.2% |
| 3 | COIMPORTEX SERVICIOS ADUANALES S.C. | 4 | $80.2K | 15.5% |
| 4 | M S | 1 | $57.9K | 11.2% |
| 5 | GRADINTER S.C | 1 | $54.7K | 10.6% |
Top 10 Moxifloxacin Formulations Imported by Mexico
Showing top 10 of 6 product formulations shipped on the India to Mexico Moxifloxacin route, ranked by trade value
Mexico imports a wide range of moxifloxacin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MIFLOKO EYE DROPS 0.5%W/V 1S MOXIFLOXACIN HYDROCHLORIDE OPTHALMIC SOLUTIONS USP ACT QTY.14994 X 1X 1 — accounts for $167.1K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MIFLOKO EYE DROPS 0.5%W/V 1S MOXIFLOXACIN HYDROCHLORIDE OPTHALMIC SOLUTIONS USP ACT QTY.14994 X 1X 1 | 1 | $167.1K | 32.4% |
| 2 | MOXIFLOXACIN 400MG TABLETS (1X7'S) | 3 | $155.9K | 30.2% |
| 3 | SAPCode 1152013 HSN Code 30042033 MIFLOKO DELTA 0 5 W V 0 1 W V 5ML 1 S MX PACK 01 01 Moxifloxacin HCL and Dexamethas | 1 | $57.9K | 11.2% |
| 4 | MIFLOKO-DELTA 0.5%W/V&0.1%W/V 5ML (MOXIFLOXACIN HCL AND DEXAMETHASONE SODIUM PHOPHATE EYE DROPS 0.5%W/V, 0.1% W/V, 5ML) | 1 | $54.7K | 10.6% |
| 5 | MOXIFLOXACINO (MOXIFLOXACIN (AS HCL)0.5%W/V EYE DROPS SOLUTION) (1X5ML) (QTY-34700)TAX INV NO:714201065/29.05.2024 | 1 | $41.1K | 8.0% |
| 6 | T & B EYE DROPS SOLUTION (MOXIFLOXACIN (AS HYDROCHLORIDE) 0.5% W/V EYE DROPS SOLUTION)(1'S) (QTY- 33950.000) TAX INV NO: | 3 | $39.1K | 7.6% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
BANGALORE AIR handles the highest volume with 4 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's moxifloxacin exports to Mexico are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, HETERO LABS LIMITED, MICRO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $51.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as moxifloxacin 400mg tablets (1x7's) and sapcode 1152013 hsn code 30042033 mifloko delta 0 5 w v 0 1 w v 5ml 1 s mx pack 01 01 moxifloxacin hcl and dexamethas, suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, GRADINTER S C is the largest importer with 1 shipments worth $167.1K USD — representing 32% of all moxifloxacin imports from India on this route.
Route Statistics
- Trade Volume
- $515.9K
- Avg. Shipment
- $51.6K
- Suppliers
- 3
- Buyers
- 5
- Transit (Sea)
- ~25 days
- Annual Growth
- +19.6%
Related Analysis
Other Moxifloxacin Routes
Unlock the Full India to Mexico Moxifloxacin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Mexico Moxifloxacin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Moxifloxacin to Mexico?
The leading Indian exporters of Moxifloxacin to Mexico are SUN PHARMACEUTICAL INDUSTRIES LIMITED, HETERO LABS LIMITED, MICRO LABS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Moxifloxacin exports from India to Mexico?
India exports Moxifloxacin to Mexico worth approximately $515.9K USD across 10 recorded shipments. The average value per shipment is $51.6K USD.
Q Which ports does India use to ship Moxifloxacin to Mexico?
The most active port of origin is BANGALORE AIR with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Mexico for Moxifloxacin?
The average transit time for Moxifloxacin shipments from India to Mexico is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Mexico Moxifloxacin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.6% with demand growth tracking at 18.6%. The route is ranked #5 among India's top Moxifloxacin export destinations globally.
Q How many suppliers are active on the India to Mexico Moxifloxacin route?
There are currently 3 active Indian suppliers exporting Moxifloxacin to Mexico. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 54% of total shipment value.
Q Who are the main importers of Moxifloxacin from India in Mexico?
The leading importers of Indian Moxifloxacin in Mexico include GRADINTER S C, XXAROXXPHAXXA SXX DXXC VX, COIMPORTEX SERVICIOS ADUANALES S.C., M S, GRADINTER S.C. GRADINTER S C is the largest buyer with 1 shipments worth $167.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Mexico export trade corridor identified from Indian Customs (DGFT) records for Moxifloxacin.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 5 importers in Mexico matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists